Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0GYCJG
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
XB-002
|
|||||
| Synonyms |
ICON-2; XB 002; XB- 002; XB-002; XB002; XB002 Tissue Factor ADC
Click to Show/Hide
|
|||||
| Organization |
Iconic Therapeutics, Inc.; Exelixis, Inc.; Exelis, Inc.
|
|||||
| Drug Status |
Phase 1 (Terminated)
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
3.3
|
|||||
| Antibody Name |
Samatatug
|
Antibody Info | ||||
| Antigen Name |
Tissue factor (F3)
|
Antigen Info | ||||
| Payload Name |
ZD02044
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Mc-PEG3-Val-Cit
|
Linker Info | ||||
| Conjugate Type |
Random Cysteines
|
|||||
| Combination Type |
zovodotin
|
|||||
